1887

Chapter 103 : Celiac Disease and Inflammatory Bowel Disease

Author: Melissa R. Snyder1
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Mayo Clinic, Hilton 2-10D, 200 First St. SW, Rochester, MN 55905
Content Type: Reference
Publication Year: 2016

Category: Immunology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Celiac Disease and Inflammatory Bowel Disease, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH103-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH103-2.gif

Abstract:

Celiac disease (CeD) and inflammatory bowel disease (IBD) are chronic inflammatory diseases affecting the gastrointestinal tract. They share certain characteristics, including autoimmune features, the presence of both gastrointestinal and systemic clinical symptoms, and pathogenic contributions by genetic and environmental factors. However, there are several stark differences that must be appreciated. The immunogenic mechanisms of the two diseases are unique, with differing contributions by the innate and adaptive immune responses. Histologically, CeD is distinct from IBD, which is useful diagnostically as well as for gaining insight into disease mechanisms. Lastly, the role of diagnostic laboratory testing, both serologic and genetic, differs greatly between CeD and IBD. The purpose of this chapter is to provide a summary of what is currently known about the pathogenesis, epidemiology, clinical presentation, and diagnostic testing for CeD and IBD.

Citation: Snyder M. 2016. Celiac Disease and Inflammatory Bowel Disease, p 983-989. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch103
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Celiac Disease and Inflammatory Bowel Disease
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818722.ch103-1,webId=/content/author/10.1128/9781555818722.ch103-1,properties={foaf_givenname=Melissa R., foaf_name=Melissa R. Snyder, foaf_surname=Snyder, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818722.ch103-aff1]]}]]
Citation: Snyder M. 2016. Celiac Disease and Inflammatory Bowel Disease, p 983-989. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch103
/content/10.1128/9781555818722.ch103.ch103fig1
FIGURE 1

EMA by indirect immunofluorescence. The presence of an EMA is identified based on the appearance of latticework staining of the endomysium surrounding the smooth muscle fiber. This photo is a 10× magnification of an indirect immunofluorescence method using monkey esophagus. (Photo courtesy of the Immunodermatology Laboratory, Mayo Clinic, Rochester, MN.)

10.1128/9781555818722/8722ch103fig1_thmb.gif
10.1128/9781555818722/8722ch103fig1.gif
Image of FIGURE 1
FIGURE 1

EMA by indirect immunofluorescence. The presence of an EMA is identified based on the appearance of latticework staining of the endomysium surrounding the smooth muscle fiber. This photo is a 10× magnification of an indirect immunofluorescence method using monkey esophagus. (Photo courtesy of the Immunodermatology Laboratory, Mayo Clinic, Rochester, MN.)

Citation: Snyder M. 2016. Celiac Disease and Inflammatory Bowel Disease, p 983-989. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch103
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818722.ch103
1. Green PH, Cellier C. 2007. Celiac disease. N Engl J Med 357:1731–1743.[CrossRef].[PubMed]
2. Di Sabatino A, Corazza GR. 2009. Coeliac disease. Lancet 373:1480–1493.[CrossRef].[PubMed]
3. Heap GA, van Heel DA. 2009. Genetics and pathogenesis of coeliac disease. Semin Immunol 21:346–354.[CrossRef].[PubMed]
4. Qiao SW, Sollid LM, Blumberg RS. 2009. Antigen presentation in celiac disease. Curr Opin Immunol 21:111–117.[CrossRef].[PubMed]
5. Jabri B, Sollid LM. 2006. Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol 3:516–525.[CrossRef].[PubMed]
6. Abadie V, Sollid LM, Barreiro LB, Jabri B. 2011. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29:493–525.[CrossRef].[PubMed]
7. Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. 2012. The prevalence of celiac disease in the United States. Am J Gastroenterol 107:1538–1544, quiz 1537, 1545.[CrossRef].[PubMed]
8. Kang JY, Kang AH, Green A, Gwee KA, Ho KY. 2013. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther 38:226–245.[CrossRef].[PubMed]
9. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, Brantner TL, Kim WR, Phelps TK, Lahr BD, Zinsmeister AR, Melton LJ III, Murray JA. 2009. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 137:88–93.[CrossRef].[PubMed]
10. Reilly NR, Green PH. 2012. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol 34:473–478.[CrossRef].[PubMed]
11. Elli L, Bonura A, Garavaglia D, Rulli E, Floriani I, Tagliabue G, Contiero P, Bardella MT. 2012. Immunological comorbity in coeliac disease: associations, risk factors and clinical implications. J Clin Immunol 32:984–990.[CrossRef].[PubMed]
12. Kárpáti S. 2012. Dermatitis herpetiformis. Clin Dermatol 30:56–59.[CrossRef].[PubMed]
13. Singh K, Chang C, Gershwin ME. 2014. IgA deficiency and autoimmunity. Autoimmun Rev 13:163–177.[CrossRef].[PubMed]
14. Oberhuber G. 2000. Histopathology of celiac disease. Biomed Pharmacother 54:368–372.[CrossRef].[PubMed]
15. van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. 2010. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 303:1738–1746.[CrossRef].[PubMed]
16. Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D. 2005. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128(Suppl 1):S38–S46.[PubMed]
17. Li M, Yu L, Tiberti C, Bonamico M, Taki I, Miao D, Murray JA, Rewers MJ, Hoffenberg EJ, Agardh D, Mueller P, Stern M, Bonifacio E, Liu E. 2009. A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol 104:154–163.[CrossRef].[PubMed]
18. Rashtak S, Ettore MW, Homburger HA, Murray JA. 2008. Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther 28:805–813.[PubMed].[CrossRef]
19. Rashtak S, Ettore MW, Homburger HA, Murray JA. 2008. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol 6:426–432, quiz 370.[CrossRef].[PubMed]
20. Lewis NR, Scott BB. 2010. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 31:73–81.[CrossRef].[PubMed]
21. Dubois PC, van Heel DA. 2008. Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol 153:162–173.[CrossRef].[PubMed]
22. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA American College of Gastroenterology. 2013. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108:656–676, quiz 677.[CrossRef].[PubMed]
23. Bai JC, Fried M, Corazza GR, Schuppan D, Farthing M, Catassi C, Greco L, Cohen H, Ciacci C, Eliakim R, Fasano A, González A, Krabshuis JH, LeMair A World Gastroenterology Organization. 2013. World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol 47:121–126.[CrossRef].[PubMed]
24. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, Mäki M, Ribes-Koninckx C, Ventura A, Zimmer KP ESPGHAN Working Group on Coeliac Disease Diagnosis, ESPGHAN Gastroenterology Committee, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. 2012. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54:136–160.[CrossRef].[PubMed]
25. Nachman F, Sugai E, Vázquez H, González A, Andrenacci P, Niveloni S, Mazure R, Smecuol E, Moreno ML, Hwang HJ, Sánchez MI, Mauriño E, Bai JC. 2011. Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. Eur J Gastroenterol Hepatol 23:473–480.[CrossRef].[PubMed]
26. Basso D, Guariso G, Fogar P, Meneghel A, Zambon CF, Navaglia F, Greco E, Schiavon S, Rugge M, Plebani M. 2009. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 55:150–157.[CrossRef].[PubMed]
27. Trigoni E, Tsirogianni A, Pipi E, Mantzaris G, Papasteriades C. 2014. Celiac disease in adult patients: specific autoantibodies in the diagnosis, monitoring, and screening. Autoimmune Dis 2014:623514. doi:10.1155/2014/623514.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1155/2014/623514
28. Kaser A, Zeissig S, Blumberg RS. 2010. Inflammatory bowel disease. Annu Rev Immunol 28:573–621.[CrossRef].[PubMed]
29. Abraham C, Cho JH. 2009. Inflammatory bowel disease. N Engl J Med 361:2066–2078.[CrossRef].[PubMed]
30. Braus NA, Elliott DE. 2009. Advances in the pathogenesis and treatment of IBD. Clin Immunol 132:1–9.[CrossRef].[PubMed]
31. Zhang Y, Li Y. 2014. Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20:91.99.[CrossRef].[PubMed]
32. Molodecky NA, Kaplan GG. 2010. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 6:339–346.[PubMed]
33. Soon IS, Molodecky NA, Rabi DM, Ghali WA, Barkema HW, Kaplan GG. 2012. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol 12:51. doi:10.1186/1471-230X-12-51.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1186/1471-230X-12-51
34. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54.e42, quiz e30.[CrossRef].[PubMed]
35. Hendrickson BA, Gokhale R, Cho JH. 2002. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15:79–94.[PubMed].[CrossRef]
36. Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, Gearry R, Goh KL, Hamid S, Khan AG, LeMair AW, Malfertheiner , Ouyang Q, Rey JF, Sood A, Steinwurz F, Thomsen OO, Thomson A, Watermeyer G. 2010. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 16:112–124.[CrossRef].[PubMed]
37. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S IBD Section of the British Society of Gastroenterology. 2011. Guidelines for the management of inflammatory bowel disease in adults. Gut 60:571–607.[CrossRef].[PubMed]
38. Kornbluth A, Sachar DB Practice Parameters Committee of the American College of Gastroenterology. 2010. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 105:501–523, quiz 524.[CrossRef].[PubMed]
39. Lichtenstein GR, Hanauer SB, Sandborn WJ Practice Parameters Committee of American College of Gastroenterology. 2009. Management of Crohn's disease in adults. Am J Gastroenterol 104:465–483, quiz 464, 484.[CrossRef].[PubMed]
40. Henderson P, Anderson NH, Wilson DC. 2014. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 109:637–645.[CrossRef].[PubMed]
41. Prideaux L, De Cruz P, Ng SC, Kamm MA. 2012. Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 18:1340–1355.[CrossRef].[PubMed]
42. Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M. 2007. IBD serological panels: facts and perspectives. Inflamm Bowel Dis 13:1561–1566.[CrossRef].[PubMed]
43. Bossuyt X. 2006. Serologic markers in inflammatory bowel disease. Clin Chem 52:171–181.[CrossRef].[PubMed]
44. Sandborn WJ, Loftus EV Jr, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmeister AR, Targan SR. 2001. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 7:192–201.[PubMed].[CrossRef]

Tables

Celiac Disease and Inflammatory Bowel Disease
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818722.ch103-1,webId=/content/author/10.1128/9781555818722.ch103-1,properties={foaf_givenname=Melissa R., foaf_name=Melissa R. Snyder, foaf_surname=Snyder, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818722.ch103-aff1]]}]]
Citation: Snyder M. 2016. Celiac Disease and Inflammatory Bowel Disease, p 983-989. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch103
/content/10.1128/9781555818722.ch103.ch103tab1
TABLE 1

Summary of serologic tests available for evaluation of suspected CeD and IBD

Generic image for table
TABLE 1

Summary of serologic tests available for evaluation of suspected CeD and IBD

Citation: Snyder M. 2016. Celiac Disease and Inflammatory Bowel Disease, p 983-989. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch103

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error